News
BLUE
1.280
-6.23%
-0.085
bluebird bio, Inc. Class Action: Levi & Korsinsky LLP Reminds bluebird bio Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 – BLUE
TipRanks · 9h ago
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUE
Rosen Law Firm announces investigation of potential securities claims on behalf of shareholders of bluebird bio Inc. Allegations that bluebird may have issued materially misleading business information to the investing public. Rosen Law Firm is a global investor rights law firm. Bluebird bio is a biotechnology company.
Barchart · 16h ago
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of bluebird bio, Inc. (BLUE) on Behalf of Investors
Glancy Prongay & Murray LLP has commenced an investigation on behalf of bluebird bio, Inc. Investors concerning the Company’s possible violations of the federal securities laws. On March 26, 2024, bluebird announced that it will restate financial statements for 2022 and 2023. The company's stock price fell 11.8% after the announcement.
Barchart · 1d ago
Peeling Back The Layers: Exploring bluebird bio Through Analyst Insights
Bluebird bio is a biotechnology company engaged in developing gene therapies for severe genetic diseases. The company has an average price target of $2.92 for the next 12 months. Bluebird bio has an impressive revenue growth rate of 17353.52% in the last three months. 4 analysts have recently shared their evaluations of bluebirds bio (NASDAQ:BLUE)
Benzinga · 1d ago
bluebird bio Price Target Maintained With a $6.00/Share by RBC Capital
Dow Jones · 1d ago
bluebird (BLUE) Misses on Q4 Revenues, Provides Portfolio Updates
NASDAQ · 1d ago
RBC Capital Reiterates Sector Perform on bluebird bio, Maintains $6 Price Target
Benzinga · 1d ago
Earnings Preview: Bluebird Bio (BLUE) Q4 Earnings Expected to Decline
NASDAQ · 1d ago
The Law Offices of Frank R. Cruz Announces Investigation of bluebird bio, Inc. (BLUE) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation of bluebird bio, Inc. On behalf of investors concerning the Company’s possible violations of federal securities laws. On March 26, 2024, bluebird announced that it will restate financial statements for 2022 and 2023. On this news bluebird's stock price fell 11.8% to close at $1.20.
Barchart · 1d ago
bluebird bio Price Target Cut to $3.00/Share From $4.00 by Wells Fargo
Dow Jones · 1d ago
bluebird bio Is Maintained at Equal-Weight by Wells Fargo
Dow Jones · 1d ago
Wells Fargo Maintains Equal-Weight on bluebird bio, Lowers Price Target to $3
Benzinga · 1d ago
BLUE LOSS ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation – BLUE
The Rosen Law Firm is preparing a class action seeking recovery of investor losses. Bluebird bio Inc. May have issued materially misleading business information to the investing public. On March 26, 2024, bluebird filed an 8-K with the SEC. The firm is investigating potential securities claims on behalf of bluebird shareholders.
Barchart · 1d ago
Bluebird Bio (BLUE) Receives a Hold from RBC Capital
TipRanks · 1d ago
Buy Rating Upheld for Bluebird Bio Amidst Revenue Miss and Promising Gene Therapy Launch
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Healthequity (HQY) and Bluebird Bio (BLUE)
TipRanks · 2d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bluebird Bio (BLUE) and BeiGene (BGNE)
TipRanks · 2d ago
Hold Rating on Bluebird Bio Amidst Gradual Patient Starts and Funding Steps
TipRanks · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Nuvation Bio, Seagate, AppFolio
Wall Street's main stock indexes climbed on Tuesday. Dow Jones Industrial Average was up 0.21% at 39,395.24. Most heavyweight growth stocks and chipmakers rose. Nuvation Bio, Seagate, AppFolio among the top percentage gainers.
Reuters · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Reddit, CONSOL Energy, Nuvation Bio
Dow Jones Industrial Average was up 0.23% on Tuesday. Top three S&P 500 percentage gainers were Seagate Technology, Nuvation Bio and Krispy Kreme. Reddit, Consol Energy and Evercore are among the biggest decliners on the NYSE.
Reuters · 2d ago
More
Webull provides a variety of real-time BLUE stock news. You can receive the latest news about Bluebird Bio Inc through multiple platforms. This information may help you make smarter investment decisions.
About BLUE
bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its lentiviral vector (LVV) gene addition platform. Its lead gene therapy programs for sickle cell disease, B-thalassemia, and cerebral adrenoleukodystrophy and is advancing research to apply new technologies to these and other diseases. It has two gene therapies: ZYNTEGLO (betibeglogene autotemcel) and SKYSONA (elivaldogene autotemcel). ZYNTEGLO is the first gene therapy for people with B-thalassemia who require regular red blood cell transfusions. SKYSONA (elivaldogene autotemcel), also known as eli-cel, is used to slow the progression of eurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). It is also developing (lovotibeglogene autotemcel), also known as lovo-cel, as a one-time treatment for patients with sickle cell disease (SCD).